In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.
Brody JD; Ai WZ; Czerwinski DK; Torchia JA; Levy M; Advani RH; Kim YH; Hoppe RT; Knox SJ; Shin LK; Wapnir I; Tibshirani RJ; Levy R; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2010, vol. 28, issue 28, p 4324, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef